Dublin, April 26, 2019 (GLOBE NEWSWIRE) -- The "Biomarkers Market Size, Share & Trends Analysis Report By Type (Safety, Efficacy, Validation), By Application (Diagnostic, Drug Development, Personalized Medicine), By Disease, And Segment Forecasts, 2019 - 2026" report has been added to ResearchAndMarkets.com's offering.

The global biomarkers market size is expected to reach over USD 118 billion by 2026. It is projected to expand at a CAGR of 14.2% during the forecast period. Technological advancements, high consumer awareness, and increasing funds for research and development (R&D) activities are collectively propelling the market growth.

Drug discovery was estimated to be one of the highest revenue generating segments of the market. Pharmaceutical companies are undertaking extensive R&D initiatives to develop targeted therapeutics. Coordinated research efforts on biomarker development is a rising trend among commercial R&D organizations, academic research institutions, federal government biomedical regulatory and research agencies, and non-profitable health foundations.

North America led the biomarker market in 2018, driven by high disease prevalence, proactive government initiatives, and substantial demand for personalized medicines. North America is anticipated to retain its leading position throughout the forecast period. Asia Pacific is expected to witness the fastest regional growth, spearheaded by India.

Some key players operating in the biomarkers market include F. Hoffmann-La Roche Ltd.; Abbott; Epigenomics AG; Agilent Technologies, Inc; Johnson & Johnson Services, Inc; Siemens Healthcare Private Limited; Bio-Rad Laboratories, Inc; Thermo Fisher Scientific, Inc; and Qiagen. Key players are developing novel kits and therapies or drugs to target population in the areas with high unmet clinical needs.

Further key findings from the study suggest:

• Safety biomarkers held the largest market share of over 42% in 2018 due to reduction in drug attrition and increasing awareness of routine healthcare check-ups
• Validation biomarkers is estimated to be one of the fastest growing segments
• Personalized medicine is estimated to grow at a CAGR of 15% over the forecast period owing to growing consumer awareness
• Cancer held the largest market share in 2018, driven by an increase in global prevalence of cancer and the presence of a strong pipeline of drugs
• Cardiovascular diseases is projected to be the fastest growing segment throughout the forecast period, supported by sedentary lifestyles and growing obese population

Key Topics Covered

Chapter 1 Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.4. Information Analysis
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Biomarkers Market Variables, Trends & Scope
3.1. Biomarkers Market Lineage outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Regulatory Framework
3.4. Market Dynamics
3.5. Biomarkers Market Analysis Tools

Chapter 4. Biomarkers Market - Competitive Analysis
4.1. Recent Developments & Impact Analysis, By Key Market Participants
4.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
4.3. Vendor Landscape
4.4. Public Companies
4.5. Private Companies

Chapter 5. Biomarkers Market: Type Estimates & Trend Analysis
5.1. Definitions & Scope
5.2. Type Market Share Analysis, 2018 & 2026
5.3. Biomarkers Market, by Type, 2014 to 2026
5.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026

Chapter 6. Biomarkers Market: Application Estimates & Trend Analysis
6.1. Definitions & Scope
6.2. Application Market Share Analysis, 2018 & 2026
6.3. Biomarkers Market, by Application, 2014 to 2026
6.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026

Chapter 7. Biomarkers Market: Disease Estimates & Trend Analysis
7.1. Definitions & Scope
7.2. Disease Market Share Analysis, 2018 & 2027
7.3. Biomarkers Market, by Disease, 2014 to 2027
7.4. Market Size & Forecasts and Trend Analyses, 2014 to 2027
7.5. Disease Market, by Type, 2014 - 2026:

Chapter 8 Biomarkers Market: Regional Estimates & Trend Analysis, by Type, Application, & Disease
8.1 Biomarkers Market: Regional Movement Analysis, 2018 & 2026
8.2 Biomarkers Market: Leading Players, 2018:
8.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
8.4 North America
8.5. Europe
8.6 Asia Pacific
8.7 Latin America
8.8 MEA

Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Heat Map Analysis of Private Companies
9.3 F-Hoffman La Roche Ltd.
9.4 Abbott
9.5 Epigenomics AG
9.6 General Electric Company
9.7 Johnson & Johnson
9.8 Thermo Fisher Scientific Inc.
9.9 Bio-Rad Laboratories Inc.
9.10 Siemens Healthcare Private Limited
9.11 Qiagen

For more information about this report visit https://www.researchandmarkets.com/r/vpj66v

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Biomarkers